Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
TapImmune, Inc.
Information provided by (Responsible Party):
Keith Knutson, Ph.D., Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01632332
First received: June 28, 2012
Last updated: April 8, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)